KYMR vs GILD: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Gilead Sciences Inc in 2026
KYMR
Kymera Therapeutics Inc
$86.14
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | KYMR | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.27B | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.6% | 0.0% | GILD |
| Gross Margin | -707.3% | 78.8% | GILD |
Analyze KYMR
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or GILD a better investment?
Comparing KYMR and GILD: Kymera Therapeutics Inc has a market cap of $7.27B while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and GILD?
KYMR (Kymera Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or GILD?
GILD has higher revenue growth at 0.0% vs -0.6% for KYMR.
Which company is more profitable: KYMR or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -707.3% for KYMR.
Which is the larger company: KYMR or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $7.27B for KYMR.
Should I buy KYMR or GILD in 2026?
Both KYMR and GILD have investment merit. KYMR trades at $86.14 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and GILD stock?
Key differences: Market Cap ($7.27B vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-707.3% vs 78.8%).